- $1.21bn
- $1.28bn
- $713.14m
- 48
- 65
- 25
- 42
Annual balance sheet for Opko Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 72.2 | 135 | 153 | 95.9 | 432 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 302 | 266 | 149 | 130 | 152 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 523 | 823 | 395 | 309 | 662 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 178 | 124 | 122 | 144 | 124 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,473 | 2,400 | 2,167 | 2,012 | 2,200 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 375 | 330 | 213 | 200 | 193 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 802 | 715 | 606 | 622 | 835 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,672 | 1,685 | 1,562 | 1,389 | 1,365 |
| Total Liabilities & Shareholders' Equity | 2,473 | 2,400 | 2,167 | 2,012 | 2,200 |
| Total Common Shares Outstanding |